Therapy Analysis & Statistics, July 2014 (p20)

Talk to Louis

+1 718 618 4302

All regions

You might be interested in: therapeutics, biotherapeutics, cancer therapeutics, more »

571-600 of about 4 600 reports

Purchase Reports From Reputable Market Research Publishers

United Therapeutics Corporation, Wright Investors' Service

United Therapeutics Corporation, Wright Investors' Service

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for United Therapeutics Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Therapy
Antisense Therapeutics Limited

Antisense Therapeutics Limited

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Antisense Therapeutics Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Therapy
Manhattan Scientifics, Inc.

Manhattan Scientifics, Inc.

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Manhattan Scientifics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
Pain Therapeutics, Inc., Wright Investors' Service

Pain Therapeutics, Inc., Wright Investors' Service

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Pain Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
Oxygen Biotherapeutics, Incorporation

Oxygen Biotherapeutics, Incorporation

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Oxygen Biotherapeutics, Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Therapy
Imarx Therapeutics, Incorporation.

Imarx Therapeutics, Incorporation.

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Imarx Therapeutics, Incorporation. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Therapy
United Therapeutics Corporation, Wright Investors' Service

United Therapeutics Corporation, Wright Investors' Service

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for United Therapeutics Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Therapy
Sorrento Therapeutics Incorporation

Sorrento Therapeutics Incorporation

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Sorrento Therapeutics Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Therapy
Osiris Therapeutics, Inc.

Osiris Therapeutics, Inc.

  • $ 55
  • Company report
  • June 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Osiris Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
Five Prime Therapeutics Inc

Five Prime Therapeutics Inc

  • $ 55
  • Company report
  • June 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Five Prime Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
Cesca Therapeutics Inc

Cesca Therapeutics Inc

  • $ 55
  • Company report
  • June 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Cesca Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
Hyperion Therapeutics Inc

Hyperion Therapeutics Inc

  • $ 55
  • Company report
  • June 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Hyperion Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
Green Cures & Botanical Distribution Inc

Green Cures & Botanical Distribution Inc

  • $ 55
  • Company report
  • June 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Green Cures & Botanical Distribution Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Therapy
Global Database of the Top 1000 Electromedical and Electrotherapeutic Equipment Producers - Company Names, Financial Performance, Key Executives, and Contact Details

Global Database of the Top 1000 Electromedical and Electrotherapeutic Equipment Producers - Company Names, Financial Performance, Key Executives, and Contact Details

  • $ 13
  • Industry report
  • August 2014
  • by Global Research & Data Services

This company database offers valuable information on top 1000 electromedical and electrotherapeutic equipment producers in the world which makes the database an invaluable resource for industry executives, ...

  • Industries : Therapy
  • Countries : World
Alnylam Pharmaceuticals, Inc. (ALNY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alnylam Pharmaceuticals, Inc. (ALNY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Alnylam Pharmaceuticals, Inc., (Alnylam) is a biopharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics based on Ribo Nucleic Acid interference ...

  • Industries : Therapy
  • Countries : United States
Cytori Therapeutics, Inc. (CYTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cytori Therapeutics, Inc. (CYTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Cytori Therapeutics, Inc. (Cytori Therapeutics) is a US-based pharmaceutical company. It undertakes the development of cell therapies based on autologous adipose-derived regenerative cells (ADRCs) ...

  • Industries : Therapy
  • Countries : United States
Anika Therapeutics, Inc. (ANIK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Anika Therapeutics, Inc. (ANIK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Anika Therapeutics, Inc. (Anika) develops, manufactures and markets therapeutic products, which are designed to repair, protect and heal bone, cartilage and soft tissue. Its products are based ...

  • Industries : Therapy
  • Countries : United States
Arno Therapeutics, Inc. (ARNI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Arno Therapeutics, Inc. (ARNI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Arno Therapeutics, Inc. (Arno Therapeutics) is a clinical stage biopharmaceutical company. It develops products for the treatment of cancer. The company's product pipeline comprises Onapristone, ...

  • Industries : Therapy
  • Countries : United States
Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc.

  • $ 55
  • Company report
  • May 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Northwest Biotherapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Therapy
Pluristem Therapeutics Inc.

Pluristem Therapeutics Inc.

  • $ 55
  • Company report
  • May 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Pluristem Therapeutics Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
Chronic Lymphocytic Leukaemia: KOL Insight

Chronic Lymphocytic Leukaemia: KOL Insight

  • $ 5 369
  • Industry report
  • May 2014
  • by Firstword Pharma

Chronic lymphocytic leukaemia (CLL) is the most common of the leukaemias, but until recently it has been underserved in terms of effective therapeutic options. However, a revolution in personalised and ...

  • Industries : Therapy
Soligenix, Inc. (Symbol:SNGX) SWOT Analysis, Strategy, Revenues and Profits

Soligenix, Inc. (Symbol:SNGX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
XOMA Corporation (XOMA) - Financial and Strategic SWOT Analysis Review

XOMA Corporation (XOMA) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2014
  • by Global Data

XOMA Corporation (XOMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Therapy
Physician Views: Idiopathic pulmonary fibrosis - on the cusp of a revolution; how will forthcoming approvals shape the treatment and development landscapes?

Physician Views: Idiopathic pulmonary fibrosis - on the cusp of a revolution; how will forthcoming approvals shape the treatment and development landscapes?

  • $ 645
  • Industry report
  • May 2014
  • by Firstword Pharma

Description Scope Data presented at last week's American Thoracic Society (ATS) conference confirmed that InterMune and Boehringer Ingelheim are on the cusp of driving a revolution in the treatment of ...

  • Industries : Therapy
  • Countries : United States
Massachusetts Institute of Technology - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Massachusetts Institute of Technology - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Massachusetts Institute of Technology (MIT) is a private research university. The institute provides education in the field of architecture and planning, engineering, humanities, arts, social sciences, ...

  • Industries : Therapy
  • Countries : United States
Trius Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Trius Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Trius Therapeutics, Inc. (Trius) is a biopharmaceutical company. The company discovers, develops and commercializes antibiotics for life-threatening infections. It has completed Phase 3 clinical ...

  • Industries : Therapy
  • Countries : United States
Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides ...

  • Industries : Therapy
  • Countries : World
GlyGenix Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlyGenix Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary GlyGenix Therapeutics, Inc. (GTI) is a biotechnology company. The company discovers and develops genes to cure metabolic disorders that are caused by single gene mutations. Its technology develops ...

  • Industries : Therapy
  • Countries : United States
Health Care Markets in China

Health Care Markets in China

  • $ 4 000
  • Industry report
  • May 2014
  • by Asia Market Information & Development Company

China's demand for Health Care has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment ...

  • Industries : Therapy
  • Countries : China
INSYS Therapeutics, Inc. - Product Pipeline Review - 2014

INSYS Therapeutics, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • May 2014
  • by Global Markets Direct

INSYS Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Insys Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Insys Therapeutics, ...

  • Industries : Therapy
  • Countries : World

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Merck KGaA

Germany

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.